Topical JAK Inhibitor Shows Itch Relief in Prurigo Nodularis Trial
Patients treated with a topical JAK inhibitor experienced significant reductions in itch as early as day 7 and greater treatment success by week 12.
Patients treated with a topical JAK inhibitor experienced significant reductions in itch as early as day 7 and greater treatment success by week 12.
Members-only platform now features an on-demand, mobile-friendly interface with personalized access to aesthetic education and CME opportunities.